PMA
GILD icon

Prudent Man Advisors’s Gilead Sciences GILD Stock Holding History

Prudent Man Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$663K Buy
+4,759
New +$666K 0.2% 94
2020
Q3 		– Sell
-9,420
Closed -$725K – 165
2020
Q2 		$725K Buy
+9,420
New +$722K 0.64% 41

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prudent Man Advisors's GILD Position: Q1 2026 in Review

Prudent Man Advisors opened a new position in Gilead Sciences (GILD) in Q1 2026: 4,759 shares worth $663K. The stake represents 0.2% of the portfolio and ranks #94 among its holdings. This is a return to the name: Prudent Man Advisors previously reported a position in GILD as recently as Q2 2020.

Prudent Man Advisors first reported a position in GILD in Q2 2020 and has held it in 2 quarters since. The position peaked at $725K in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Prudent Man Advisors held 4,759 shares of Gilead Sciences worth $663K as of Q1 2026.
  • Gilead Sciences was a new Prudent Man Advisors position in Q1 2026.
  • Gilead Sciences made up 0.2% of Prudent Man Advisors's portfolio in Q1 2026, its #94 holding.
  • Prudent Man Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 2 quarters since.
  • Prudent Man Advisors's Gilead Sciences position peaked at $725K in Q2 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.